仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Samalizumab （ALXN 6000） is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor （CD200R）. Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research